Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.62 | N/A |
| PEG Ratio (TTM) | 3.32 | N/A |
| P/S Ratio (TTM) | 3.44 | N/A |
| P/B Ratio (TTM) | 1.15 | N/A |
| P/FCF Ratio (TTM) | 7.84 | N/A |
| Price to 5YR AVG Earnings Ratio | 4.71 | N/A |
| Price to 5YR AVG FCF Ratio | 4.26 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.21% | N/A |
| ROE (TTM) | 10.28% | N/A |
| Net Profit Margin (TTM) | 29.76% | N/A |
| ROIC 5YR AVG | 14.98% | N/A |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.69% | 3.20% | 8.62% |
| Revenue | 209.38% | 23.21% | 18.92% |
| Net Income | 3.56% | 21.01% | 22.24% |
| Cash Flow | 42.77% | 16.68% | 21.75% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.19 | N/A |
| Quick Ratio (TTM) | 0.19 | N/A |
| D/E Ratio (TTM) | 0.26 | N/A |
| Interest Coverage (TTM) | 0.81 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 1.19 | N/A |
| Shares Outstanding Growth 5YR AVG | 10.49% | N/A |